Thomas E Boyd Selected Research

Thomas E Boyd Research Topics

4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2018 - 03/2007
3	Neoplasms (Cancer) 01/2021 - 01/2013
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2018 - 06/2014
2	Lymphoma (Lymphomas) 01/2021 - 04/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 12/2016
2	Thrombocytopenia (Thrombopenia) 01/2018 - 03/2007
2	Neutropenia 12/2016 - 08/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2016 - 08/2014
1	Pneumonia (Pneumonitis) 12/2016
1	Colitis 12/2016
1	Diarrhea 12/2016
1	Exanthema (Rash) 12/2016
1	Disease Progression 10/2016
1	Hematologic Neoplasms (Hematological Malignancy) 06/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2013
1	Opportunistic Infections (Opportunistic Infection) 03/2007
1	Tumor Lysis Syndrome 03/2007
1	Second Primary Neoplasms (Neoplasms, Second) 03/2007

4	Rituximab (Mabthera)FDA Link 01/2021 - 04/2013
3	Bendamustine Hydrochloride FDA Link 01/2021 - 12/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2014
2	Bevacizumab (Avastin)FDA Link 01/2021 - 08/2014
2	idelalisibIBA 06/2018 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 02/2018 - 03/2007
2	Azacitidine (5 Azacytidine)FDA Link 01/2018 - 06/2014
2	oblimersen (G3139)IBA 11/2009 - 03/2007
2	fludarabineIBA 11/2009 - 03/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2009 - 03/2007
1	Sunitinib (Sutent)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	SpermineIBA 01/2021
1	ofatumumab FDA Link 01/2021
1	PolyaminesIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	(N(1),N(12))bis(ethyl)- 6,7- dehydrospermineIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Lenalidomide (CC 5013)FDA Link 02/2018
1	ACE-011IBA 02/2018
1	HematinicsIBA 02/2018
1	Activin Receptors (Activin Receptor)IBA 02/2018
1	cc-486IBA 01/2018
1	Transaminases (Aminotransferases)IBA 12/2016
1	LY2603618IBA 10/2016
1	Pemetrexed (MTA)FDA Link 10/2016
1	Toll-Like Receptor 9IBA 08/2014
1	PlatinumIBA 08/2014
1	IMO-2055IBA 08/2014
1	ElectrolytesIBA 08/2014
1	Vorinostat FDA Link 04/2013
1	Carboplatin (JM8)FDA LinkGeneric 04/2013
1	Etoposide (VP 16)FDA LinkGeneric 04/2013
1	IceIBA 04/2013
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2013
1	ibrutinibIBA 01/2013
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	CytokinesIBA 03/2007

3	Therapeutics 01/2021 - 08/2014
3	Drug Therapy (Chemotherapy) 08/2014 - 03/2007